Functional impairment in body dysmorphic disorder: A prospective, follow-up study

Journal of Psychiatric Research

Volumn 42, Issue 9, 2008, Pages 701-707

  Phillips, Katharine A ^a,c   Quinn, Gene ^a,d   Stout, Robert L ^b,c  

^a BUTLER HOSPITAL   (United States)

^b Pacific Institute for Research and Evaluation   (United States)

^c BROWN UNIVERSITY   (United States)

^d STONEHILL COLLEGE   (United States)

Author keywords

Body dysmorphic disorder; Delusional disorder; Dysmorphophobia; Functioning; Prospective; Somatoform disorders

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY DYSMORPHIC DISORDER; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROBABILITY; SOCIAL PSYCHOLOGY;

ADOLESCENT; ADULT; BODY IMAGE; DELUSIONS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOLOGY; SOCIAL BEHAVIOR; SOMATOFORM DISORDERS;

EID: 43049153247     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2007.07.010     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Bienvenu O.J., Samuels J.F., Riddle M.A., Hoehn-Saric R., Liang K.Y., Cullen B.A., et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biological Psychiatry 48 (2000) 287-293
3. Eisen J.L., Phillips K.A., Baer L., Beer D.A., Atala K.D., and Rasmussen S.A. The Brown Assessment of Beliefs Scale: reliability and validity. American Journal of Psychiatry 155 (1998) 102-108
4. Eisen J.L., Phillips K.A., Coles M.E., and Rasmussen S.A. Insight in obsessive compulsive disorder and body dysmorphic disorder. Comprehensive Psychiatry 45 (2004) 10-15
5. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) (1997), American Psychiatric Press, Washington, DC
6. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders: Non-Patient Edition (SCID-I N/P) (1996), NYSPI, New York
7. Goisman R.M., Warshaw M.G., Peterson L.G., Rogers M.P., Cuneo P., Tomlin-Albanese J.M., et al. Panic, agoraphobia, and panic with agoraphobia: data from a multi-center anxiety disorder study. Journal of Nervous and Mental Disease 182 (1994) 72-79
8. Hollander E., Allen A., Kwon J., Aronowitz B., Schmeidler J., Wong C., et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder. Archives of General Psychiatry 56 (1999) 1033-1039
9. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Leon A.C., Solomon D.A., et al. Psychosocial disability in the course of bipolar I and II disorders. Archives of General Psychiatry 62 (2005) 1322-1330
10. Judd L.L., Akiskal H.S., Zeller P.J., Paulus M., Leon A.C., Maser J.D., et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Archives of General Psychiatry 57 (2000) 375-380
11. Keller M.B., Lavori P.W., Friedman B., Nielsen E., Endicott J., McDonald-Scott P., et al. The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44 (1987) 540-548
12. Keller M.B., and Shapiro R.W. Major depressive disorder: initial results from a one-year prospective naturalistic follow-up study. The Journal of Nervous and Mental Disease 169 (1981) 761-768
13. Kupfer D.J. Dimensional models for research and diagnosis: a current dilemma. Journal of Abnormal Psychology 114 (2005) 557-559
14. Leon A.C., Solomon D.A., Mueller T.I., Turvey C.L., Endicott J., and Keller M.B. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychological Medicine 29 (1999) 869-878
15. Morselli E. Sulla dismorfofobia e sulla tafefobia. Bolletinno della R Accademia di Genova 6 (1891) 110-119 [translated by Jerome L., 2001. History of Psychiatry, 103-14]
16. Neziroglu F., and Khemlani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectrums 7 (2002) 464-471
17. O'Leary D., Costello F., Niall G., and Webb M. Remission onset and relapse in depression: an 18-month prospective study of course for 100 first admission patients. Journal of Affective Disorders 57 (2000) 159-171
18. Pagano M.E., Skodol A.E., Stout R.L., Shea M.T., Yen S., Grilo C.M., et al. Stressful life events as predictors of functioning: findings from the Collaborative Longitudinal Personality Disorders Study. Acta Psychiatrica Scandinavica 110 (2004) 421-429
19. Phillips K.A. Body dysmorphic disorder: the distress of imagined ugliness. American Journal of Psychiatry 148 (1991) 1138-1149
20. Phillips K.A. Quality of life for patients with body dysmorphic disorder. Journal of Nervous and Mental Disease 188 (2000) 170-175
21. Phillips K.A. Psychosis in body dysmorphic disorder. Journal of Psychiatric Research 38 (2004) 63-72
22. Phillips K.A. An open-label study of escitalopram in body dysmorphic disorder. International Clinical Psychopharmacology 21 (2006) 177-179
23. Phillips K.A., Albertini R.S., and Rasmussen S.A. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of General Psychiatry 59 (2002) 381-388
24. Phillips K.A., Hollander E., Rasmussen S.A., Aronowitz B.R., DeCaria C., and Goodman W.K. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacology Bulletin 33 (1997) 17-22
25. Phillips K.A., McElroy S.L., Keck Jr. P.E., Pope Jr. H.G., and Hudson J.I. Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 150 (1993) 302-308
26. Phillips K.A., Menard W., Fay C., and Pagano M. Psychosocial functioning and quality of life in body dysmorphic disorder. Comprehensive Psychiatry 46 (2005) 254-260
27. Phillips K.A., Menard W., Fay C., and Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with BDD. Psychosomatics 46 (2005) 317-332
28. Phillips K.A., Menard W., Pagano M., Fay C., and Stout R.L. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. Journal of Psychiatric Research 40 (2006) 95-104
29. Phillips K.A., and Najjar F. An open-label study of citalopram in body dysmorphic disorder. Journal of Clinical Psychiatry 64 (2003) 715-720
30. Phillips K.A., Pagano M.E., and Menard W. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity. Annals of Clinical Psychiatry 18 (2006) 251-257
31. Phillips K.A., Pagano M.E., Menard W., Fay C., and Stout R.L. Predictors of remission from body dysmorphic disorder: a prospective study. Journal of Nervous and Mental Disease 193 (2005) 564-567
32. Phillips K.A., and Rasmussen S.A. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics 45 (2004) 438-444
33. Rief W., Buhlmann U., Wilhelm S., Borkenhagen A., and Brahler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychological Medicine 36 (2006) 877-885
34. Schatzberg A.F., and Rothschild A.J. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?. American Journal of Psychiatry 149 (1992) 733-745
35. Skodol A.E., Pagano M.E., Bender D.S., Shea M.T., Gunderson J.G., Yen S., et al. Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychological Medicine 35 (2005) 443-451
36. Steketee G., Perry J.C., Goisman R.M., Warshaw M.G., Massion A.O., Peterson L.G., et al. The Psychosocial Treatments Interview for anxiety disorders: a method for assessing psychotherapeutic procedures in anxiety disorders. Journal of Psychotherapy Practice and Research 6 (1997) 45-61
37. Ware Jr. J.E. SF-36 health survey manual and interpretation guide (1993), The Health Institute, New England Medical Center, Boston
38. Wells K.B., Stewart A., Hays R.D., Burnam A., Rogers W., Daniels M., et al. The functioning and well-being of depressed patients. Journal of the American Medical Association 262 (1989) 914-919